| Term 
 
        |       Acetylcholinesterase inhibitors |  | Definition 
 
        |   - they aren't parasympathomimetics   - can mimic the effects of parasympathetic stimulation and other kinds of stimulation too- they produce skeletal muscle contractility as a potential effect, as well as CNS effects |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     - group of agents which, for the most part, are either muscarinic agonists or indirect-acting parasympathomimetics - agent that mimics the effects of parasympathetic stimulation     |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   - mimic the effects of acetylcholine (Ach) - Ach acts at a bunch of places; it has nicotinic or muscarinic effects - we use parasympathomimetic instead of cholinomimetic   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   - parasympathomimetic, but they can ALSO mimic the effects of sympathetic stimulation,  **ex. a muscarinic agonist will produce an increase in sweating, and that's mediated by a sympathetic cholinergic nerve   |  | 
        |  | 
        
        | Term 
 
        |       Indirect-acting Parasympathomimetics |  | Definition 
 
        |        - carbachol; at its lowest doses it produces indirect parasympathomimetic-like effects   |  | 
        |  | 
        
        | Term 
 
        |       Acetylcholinesterase (AchE) Inhibitors |  | Definition 
 
        |  - can increase Ach levels; (Ach acts as a neurotransmitter at the  neuroeffector junction between cholinergic  nerves and muscarinic receptors) - they can also produce nicotinic effects, because Ach acts at different places   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     -parasympathomimetics  - AchE inhibitors - depolarizing neuromuscular blockers   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |       depolarizing neuromuscular blocker  |  | 
        |  | 
        
        | Term 
 
        |     In Vivo Diagnostics (parasympathomimetics) |  | Definition 
 
        | - methacholine can produce contraction of bronchial smooth muscle - one can diagnose for pulmonary hyper-reactivity  by administering increasing doses (concentrations) of agents, including methacholine - people who have hyper-reactivity of the respiratory tract will develop a contractile response at very low doses in the inspired air; this can be alleviated by giving a beta-2 agonist   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   Nicotine     Pilocarpine    Muscarine      Arecholine  |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |       - it is the prototype nicotinic receptor agonist - it also produces an inactivation of the nicotinic receptor on continual stimulation  - it is a natural cholinomimetic   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     - muscarinic agonist; acts on muscarinic receptors; has affinity and intrinsic activity,  - it is still used   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |       - found in mushrooms - it's able to stimulate muscarinic receptors   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   - naturally occurring cholinomimetic   - found in beetle nut  - it mimics the effects of cholinergic stimulation  and has muscarinic agonist activity;  - not used at present  |  | 
        |  | 
        
        | Term 
 
        |       Indirect-acting parasympathomimetics   |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
   - also known as Reglan - acts as an indirect-acting parasympathomimetic; - it promotes the release of Ach from cholinergic post-ganglionic nerve terminal endings   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     Methacholine- synthetic choline ester Bethanecol- synthetic choline ester Cevimeline- synthetic muscarinic agonist  Pilocarpine- naturally-occurring muscarinic agonist   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   - not first choice of drug, because:             1. lacks selectivity, it acts at all cholinergic receptors             2. it's broken down very quickly by AchE Naturally occurring, non-selective action       |  | 
        |  | 
        
        | Term 
 
        |       Uses for Parasympathomimetics   |  | Definition 
 
        |   - narrow-angle glaucoma - urinary Retention - GERD - Sjogren's Syndrome - In Vivo Diagnostics       |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
   - Methacholine - Carbachol - Bethanechol  |  | 
        |  | 
        
        | Term 
 
        |       Cholinesterase Susceptibility |  | Definition 
 
        |   - Ach is MOST susceptible to AchE (3+) - methacholine is susceptible to AchE to a degree (1+) - carbachol and bethanecol are not broken down by AchE, but the effect of carbachol can be influenced by cholinesterase   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - the effects of carbachol can be influenced by cholinesterase; it depends on release of Ach at low doses, so even though carbachol itself is not broken down by AchE, an AchE inhibitor could potentiate the effects of low-dose carbachol because it acts to promote the release of Ach, which itself is susceptible to AchE     |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - has very prominent cardiovascular effects!!! - it's rarely used systemically due to cardiovascular receptor affinity - Ach is 2+ for cardiovascular, but methacholine is much more potent because methacholine is not broken down as readily as Ach     |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | - competitive muscarinic receptor antagonist; - it antagonizes the effects of Ach on muscarinic receptors, as well as methacholine on muscarinic receptors - carbachol has nicotinic effects as well as muscarinic effects, so it is not very  well-antagonized by atropine - bethanechol and cevimeline are antagonized by atropine;     |  | 
        |  | 
        
        | Term 
 
        |       Metoclopramide and bethanechol |  | Definition 
 
        |      - used in GERD to increase the lower esophageal sphincter tone; they also promote emptying of stomach   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |  - increase in intraocular fluid pressure - can be genetic, NOT reversible! - glucocorticoids increase your risk for glaucoma - the continued elevation of IO fluid results in damage to the optic nerve; vision loss - occurs very gradually   |  | 
        |  | 
        
        | Term 
 
        |       Glaucoma & how drugs work here |  | Definition 
 
        | - the IO fluid goes through Canal of Schlemm - some of the drugs used in glaucoma act by producing contraction of the pupillary sphincter, and as a consequence relieve the blockage of the Canal of Schlemm (narrow-angle glaucoma) - some agents act by causing a decrease in the production of aqueous humor, decrese IOP - parasympathomimetics, sympathomimetics and prostaglandin derivatives are used   |  | 
        |  | 
        
        | Term 
 
        |       ANS Drug Mechanisms in Glaucoma |  | Definition 
 
        |       1. increase aqueous humor drainage 2. decrease aqueous humor formation     |  | 
        |  | 
        
        | Term 
 
        |       Increase aqueous humor drainage |  | Definition 
 
        | -pilocarpine and carbachol - can use parasympathomimetics, as they cause contraction of the sphincter muscle, or AchE inhibitors, as they increase the levels of Ach (also causing contraction of the sphincter muscle); these are called miotics, because they produce miosis     |  | 
        |  | 
        
        | Term 
 
        |       Decrease aqueous humor formation  |  | Definition 
 
        | - carbonic anhydrase inhibitors, and prostaglandin derivatives        alpha-1 agonists- act on cilliary vessels              alpha-2 agonists- act on the cilliary body              beta-1 antagonists- act on the cilliary body to reduce aqueous humor formation     |  | 
        |  | 
        
        | Term 
 
        |       Pilocarpine and carbachol |  | Definition 
 
        | Increase aqueous humor drainage or "improve uveoscleral outflow"    - used topically because they can produce effects at other muscarinic receptors if used systemically - they increase parasympathetic stimulation   |  | 
        |  | 
        
        | Term 
 
        |       Bethanechol and carbachol |  | Definition 
 
        | - used in urinary retention as they increase  activity of the detrusor muscle    - they can produce effects wherever there are muscarinic receptors (or for carbachol, a cholinergic nerve); not preferred agents - bethanechol is preferred over carbachol     |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 
  - Ach is used as a miotic for surgery - it's administered into the eye, where it produces miosis for surgical procedures of the eye - can't be used systemically as it has non-selective effects   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |       B-2 agonist for bronchoconstriction reversal  |  | 
        |  | 
        
        | Term 
 
        |       Pilocarpine and cevimeline |  | Definition 
 
        | - used to combat xerostomia - Pilocarpine is used as topical drops in the mouth to promote salivation - Cevimeline is an agent which is used specifically in Sjogren's; it increases the exocrine grandular secretions   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   - these agents are used orally and/or topically; NOT IV or SC because they will work at all muscarinic receptors; - bethanechol has a very high GI propensity, but it will produce bradycardia if it gets systemically   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |   - miotics (AchE inhibitors) may cause bronchoconstriction, so don't use in asthma! - parasympathomimetics can worsen  the symptoms of angina, as they cause bradycardia -  do NOT be use in peptic ulcers  
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - a muscarinic agonist or AchE inhibitor will cause an increase in contractility of the pupil, so you get miosis AND accomodation for near vision;  - muscarinic agonists can cause visual blurring and impaired depth perception - you won't be able to dilate your pupils, so it's difficult to drive at night;    |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - parasympathetic stimulation causes bradycardia, (a/v block); - people who take beta-blockers have unopposed parasympathetic stimulation of the heart, and so giving a muscarinic agonist or a  parasympathomimetic will increase the slowing of the heart because you have beta-blockade and less sympathetic stimulation, (which is producing the opposite effect of parasympathetic stimulation) - people taking beta-blockers will have a greater likelihood of developing cardiac conduction disturbances***   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |      - is broken down by CYP2D6, so people who have  deficiencies in this enzyme will be very sensitive  to the effects of cevimeline  |  | 
        |  | 
        
        | Term 
 
        |       Muscarinic Receptor Antagonists |  | Definition 
 
        |     - block the effects of Ach - block the effects of muscarinic agonists - can produce CNS effects if they can get there   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     - prototype muscarinic receptor antagonists  - able to get into CNS, as well as periphery - "belladonna alkaloids", naturally occurring muscarinic receptor antagonists   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - has atropine-like effects - can get into CNS, and unlike atropine,  it can produce sedation; used in preparation for surgery as (1) enhances the effects of the general anesthetic (2) combats some side-effects of GA (excessive salivation, broncho-secretions) - it blocks muscarinic receptors, - can also combat motion sickness but causes dry mouth           |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     - belladonna alkaloid like atropine - effects are comparable to atropine - does not produce sedation like scopolamine   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     
 - not a belladonna alkaloid - it is a synthetic muscarinic receptor antagonist     |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - drugs that can block the effects of Ach; 2 kinds:             1. drugs that can get into CNS and block Ach receptors in CNS= anticholinergics             2. drugs which have antagonistic activity toward muscarinic AND nicotinic receptors; these are antagonists at cholinergic receptors   |  | 
        |  | 
        
        | Term 
 
        |       CNS-acting anticholinergics |  | Definition 
 
        |   - used in combatting diseases like Parkinsons; - will still have peripheral muscarinic side-effects and precautions associated with peripherally-acting muscarinic antagonists  |  | 
        |  | 
        
        | Term 
 
        |     Quaternary Ammonium Muscarinic Antagonist   |  | Definition 
 
        |     Ipratropium  Tiotropium   Methscopolamine      |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - used in respiratory difficulty; it blocks muscarinic receptors (Quaternary Ammonium Muscarinic Antagonist) - can't produce relaxation of bronchial smooth muscle because the muscarinic receptors on the pulmonary tissue are non-innervated - it's included in some respiratory preparations with beta-2 agonists, which will produce relaxation in bronchial smooth muscle.   |  | 
        |  | 
        
        | Term 
 
        |       Methscopolamine= scopolamine methylbromide |  | Definition 
 
        | 
 - quaternary ammonium muscarinic receptor antagonists - don't have any CNS effects - produce only peripheral effects   |  | 
        |  |